Medicare Enrolled

Dr. Aditya Sharma, M.D.

Psychiatry · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7777 FOREST LN, Dallas, TX 75230
9725664591
In practice since 2007 (19 years)
NPI: 1659410322 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sharma

Dr. Aditya Sharma is a psychiatry specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sharma performed 69 Medicare services across 32 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sharma received a total of $24,956 from 45 pharmaceutical and/or device companies across 1108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 69 Medicare services $24,956 industry payments

Medicare Practice Summary

Medicare Utilization ↗
69
Medicare services
Bottom 23% in TX for psychiatry
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
32
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 53 $85 $203
Psychiatric diagnostic evaluation with medical services 16 $127 $340
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$24,956
Total received (2018-2024)
Avg $3,565/year across 7 years
Top 4% in TX for psychiatry
45
Companies
1,108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,207 (73.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,591 (22.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,158 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,136
2023
$2,677
2022
$2,459
2021
$3,332
2020
$3,433
2019
$2,410
2018
$7,508

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$5,075
Tris Pharma Inc
$2,006
Sunovion Pharmaceuticals Inc.
$1,891
Neuronetics, Inc.
$1,649
Lundbeck LLC
$1,251
Janssen Pharmaceuticals, Inc
$1,183
Ironshore Pharmaceuticals Inc.
$897
Neos Therapeutics, LP
$887
Teva Pharmaceuticals USA, Inc.
$761
AbbVie Inc.
$760
Validus Pharmaceuticals LLC
$717
ABBVIE INC.
$639
Corium, LLC
$577
Takeda Pharmaceuticals U.S.A., Inc.
$555
ITI, Inc.
$532
Neurocrine Biosciences, Inc.
$448
Avanir Pharmaceuticals, Inc.
$441
Allergan Inc.
$369
Shire North American Group Inc
$336
Supernus Pharmaceuticals, Inc.
$332
Alkermes, Inc.
$309
Bausch Health US, LLC
$297
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$264
Allergan, Inc.
$260
ARBOR PHARMACEUTICALS, INC.
$236
Vanda Pharmaceuticals Inc.
$215
Rhodes Pharmaceuticals L.P.
$204
Vertical Pharmaceuticals, LLC
$198
Almatica Pharma LLC
$178
Adlon Therapeutics L.P.
$175
Noven Therapeutics, LLC
$174
IDORSIA PHARMACEUTICALS US INC
$169
Axsome Therapeutics, Inc.
$163
Merck Sharp & Dohme Corporation
$160
IRONSHORE PHARMACEUTICALS INC.
$155
Eisai Inc.
$95
JAZZ PHARMACEUTICALS INC.
$89
Penumbra, Inc.
$64
Indivior Inc.
$60
LivaNova USA, Inc.
$47
Arbor Pharmaceuticals, Inc.
$32
Alfasigma USA, Inc.
$32
PFIZER INC.
$30
Corium, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 35.9% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · COTEMPLA XR-ODT · Cotempla XR-ODT · Dayvigo · Dyanavel XR · Equetro · Evekeo · Evekeo ODT · Fanapt · GRALISE · HETLIOZ · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LONHALA MAGNAIR · LOREEV XR · LYBALVI · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · Nuedexta · PERSERIS · Penumbra System · QELBREE · QUILLICHEW ER · QUILLIVANT XR · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · Quillivant XR · REXULTI · Relexxii · SECUADO · SERTRALINE HCL · SPRAVATO · SUBLOCADE · SUNOSI · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VRAYLAR · VYVANSE · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for psychiatry in TX.

Equivalent to $36,168 per 100 Medicare services performed
Looking for a psychiatry specialist in Dallas?
Compare psychiatrists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
580
Per 100K population
22.3
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sharma is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sharma experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sharma performed 53 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $24,956 from 45 companies across 1,108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other psychiatrists in Dallas?
Dr. Sharma's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →